- Home
- SIF vs MRSN Comparison
SIF vs MRSN Comparison
Compare SIF & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- MRSN
- Stock Information
- Founded
- SIF 1913
- MRSN 2001
- Country
- SIF United States
- MRSN United States
- Employees
- SIF N/A
- MRSN N/A
- Industry
- SIF Office Equipment/Supplies/Services
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- MRSN Health Care
- Exchange
- SIF Nasdaq
- MRSN Nasdaq
- Market Cap
- SIF 34.9M
- MRSN 37.0M
- IPO Year
- SIF N/A
- MRSN 2017
- Fundamental
- Price
- SIF $7.00
- MRSN $7.16
- Analyst Decision
- SIF
- MRSN Strong Buy
- Analyst Count
- SIF 0
- MRSN 4
- Target Price
- SIF N/A
- MRSN $63.67
- AVG Volume (30 Days)
- SIF 33.9K
- MRSN 137.0K
- Earning Date
- SIF 08-14-2025
- MRSN 08-13-2025
- Dividend Yield
- SIF N/A
- MRSN N/A
- EPS Growth
- SIF N/A
- MRSN N/A
- EPS
- SIF N/A
- MRSN N/A
- Revenue
- SIF $83,663,000.00
- MRSN $34,769,000.00
- Revenue This Year
- SIF N/A
- MRSN N/A
- Revenue Next Year
- SIF N/A
- MRSN $1.03
- P/E Ratio
- SIF N/A
- MRSN N/A
- Revenue Growth
- SIF 35.71
- MRSN 16.14
- 52 Week Low
- SIF $2.33
- MRSN $5.21
- 52 Week High
- SIF $7.40
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- SIF 75.53
- MRSN 48.25
- Support Level
- SIF $5.61
- MRSN $5.21
- Resistance Level
- SIF $6.25
- MRSN $7.72
- Average True Range (ATR)
- SIF 0.44
- MRSN 0.53
- MACD
- SIF 0.12
- MRSN 0.07
- Stochastic Oscillator
- SIF 86.93
- MRSN 77.84
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.